openPR Logo
Press release

Athingforstyling Makes Home Decorating Simple with Virtual Design Services Nationwide

08-15-2025 11:06 PM CET | Associations & Organizations

Press release from: ABNewswire

Athingforstyling Makes Home Decorating Simple with Virtual

Athingforstyling, a boutique interior design brand based in New York, is making it easier than ever for people across the USA to create their dream homes. Led by founder and home decor expert Sara Ghalayini, the company offers virtual interior design services that are simple, affordable, and tailored to each client's needs. With over 10 years of experience and more than 300 happy clients, Athingforstyling is helping homeowners and renters transform their spaces without stress or confusion.

Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXeNw3o9DN7EhD_JCtL249hMy0yQAYaNZdzoGfB33AdYJxaI0qt9J0Z-DLxJ-cVgtqOAlaL6rih_bHDKGzchjh7YTeljHPFjfQSnZm6xzqpN2PsphAOAVCQweynxHxWXWnP2HTjm?key=rkBJgw91E6Mz7CDSw1Deeg

Many people want a beautiful home but are unsure where to start. They worry about making expensive mistakes, wasting time, or buying the wrong furniture. Some are simply too busy to manage the process on their own. Athingforstyling understands these challenges and has designed a virtual service that makes decorating easy from start to finish. Clients can enjoy the expertise of a professional designer without having to leave home or commit to large budgets.

The process of the virtual interior design services [https://www.athingforstyling.com/] offered by Athingforstyling is straightforward. Clients begin by filling out a short questionnaire and sharing photos, room dimensions, and inspiration images. Based on this information, the Athingforstyling team creates a personalized design plan that matches the client's style, lifestyle, and budget. This plan is delivered entirely online, making it accessible to anyone in the country. Clients can choose from 2D or 3D design boards, each showing how their finished room will look. They also receive a clickable shopping list, making it easy to order all the recommended furniture and decor at their own pace.

Sara Ghalayini, the founder and principal designer, has a BA in Interior Design and has spent over a decade creating stylish, functional homes. Since launching virtual design services in 2021, she has worked with clients from coast to coast. Her approach blends beauty and practicality, ensuring that each space is both elegant and suited to everyday living. She believes that luxury should not be limited to special occasions, but should be part of daily life.

Athingforstyling is known for its attention to detail and ability to listen closely to what clients want. Every design is unique, reflecting the client's personality while making the most of the available space. Whether the look is modern and minimal, classic and timeless, or colorful and bold, the result is always intentional and well-coordinated. The brand also has no budget minimums, making high-quality design more accessible to people at different price points.

Working virtually means clients save both time and money. There is no need for lengthy in-person meetings or trips to furniture stores. Everything is handled online, with clear communication and step-by-step guidance from the design team. This convenience is especially valuable for busy professionals, families, and anyone who wants a stress-free way to improve their home.

About Athingforstyling

The company's growing reputation is built on trust, creativity, and a commitment to client satisfaction. As more people discover the benefits of virtual design, Athingforstyling is becoming a go-to choice for those who want a beautiful, functional home without the hassle. From a single room makeover to a full home redesign, the team is ready to bring elegance and comfort to any space.

Media Contact
Company Name: Athingforstyling
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=athingforstyling-makes-home-decorating-simple-with-virtual-design-services-nationwide]
Address:1178 Broadway 3rd Floor #1016
City: New York
State: NY 10001
Country: United States
Website: https://www.athingforstyling.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Athingforstyling Makes Home Decorating Simple with Virtual Design Services Nationwide here

News-ID: 4146607 • Views:

More Releases from ABNewswire

Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therapeu
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Polycythemia Vera pipeline constitutes 8+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsigh …
The Key Myelofibrosis Companies in the market include - Lynk Pharmaceuticals, Samus Therapeutics, Taiga Biotechnologies, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Inc., Keros Therapeutics, Inc., Galecto Biotech AB, Actuate Therapeutics Inc., Karyopharm Therapeutics, AbbVie, Sierra Oncology, and others. DelveInsight's "Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology as well as the Myelofibrosis market trends in the United States, EU4 (Germany, Spain,
Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentec
Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Obser …
The Key Asthma Companies in the market inlcude - GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharmaceuticals, Inc., AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharmaceuticals, Genentech Research, Roche, Suzhou Connect Biopharmaceuticals, Avalo Therapeutics, 4D Pharma plc, Regeneron Pharmaceuticals, RAPT Therapeutics, Inc., Incyte Corporation, Areteia Therapeutics, Suzhou Connect Biopharmaceuticals, Ltd., Cumberland Pharmaceuticals, Pulmatrix Inc., and others. DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Asthma, historical and
Inflammatory Bowel Disease Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly and Company, Gilead
Inflammatory Bowel Disease Market Positioned for Accelerated Development Through …
The Key Inflammatory Bowel Disease Companies: AbbVie, Janssen Pharmaceuticals, Abivax, Morphic Therapeutic, CJ Bioscience/4D Pharma, RedHill Biopharma, Tryp Therapeutics, Eli Lilly and Company, Gilead, Galapagos, Applied Molecular Transport, Protagonist Therapeutics, Janssen, AstraZeneca, Vifor Pharma, Astellas Pharma, Shield Therapeutics, Takeda, Ocera Therapeutics, Sanofi, Morphic Therapeutic, Inc., Bausch Health Americas, Inc., Qu Biologics Inc., Vifor Pharma, and others DelveInsight's "Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding

All 5 Releases